Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients

• Lauren E. Kushner,

  Affiliation Veterans Affairs Palo Alto Health Care System, Palo Alto, California, United States of America

  ⨯
• Aaron M. Wendelboe,

  Affiliation University of Oklahoma, Oklahoma City, Oklahoma, United States of America

  ⨯
• Laura C. Lazzeroni,

  Affiliation Stanford University, Stanford, California, United States

  ⨯
• Aarthi Chary,

  Affiliations Veterans Affairs Palo Alto Health Care System, Palo Alto, California, United States of America, Stanford University, Stanford, California, United States

  ⨯
• Mark A. Winters,

  Affiliations Veterans Affairs Palo Alto Health Care System, Palo Alto, California, United States of America, Stanford University, Stanford, California, United States

  ⨯
• Anu Osinusi,

  Affiliation Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

  ⨯
• Shyam Kottilil,

  Affiliation Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

  ⨯
• Michael A. Polis,

  Affiliation Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

  ⨯
• Mark Holodniy

  * E-mail: mark.holodniy@va.gov

  Affiliations Veterans Affairs Palo Alto Health Care System, Palo Alto, California, United States of America, Stanford University, Stanford, California, United States

  ⨯